The Future of theDesalination Technologies Market: Growth Trends, Market Size, and Opportunities to Watch
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Drivers Are Shaping the Growth and Development of theDesmoid Tumors Market?
The anticipated surge in cancer incidents is predicted to significantly enhance the progress of the desmoid tumor market in the future. Cancer is essentially a broad term for a group of diseases, distinguished by the abnormal and uncontrollable growth and spread of cells within the body, which potentially harm nearby tissues and organs. The escalating number of global cancer incidents has stimulated the need for sophisticated and effective chemotherapeutic agents, thus positively impacting the desmoid tumor market. For example, the U.S. Federal agency National Cancer Institute predicts that in 2024, 2,001,140 new cancer cases and 611,720 cancer-related fatalities are expected within the U.S. The agency recorded nearly 20 million new cancer cases and 9.7 million cancer-related deaths globally in 2022. They also predict that by 2040, the annual new cancer cases will touch 29.9 million and cancer-led deaths will reach about 15.3 million. As a result, this surge in cancer incidents is fueling the growth of the desmoid tumor market. An escalated allocation of government funds towards research and development is anticipated to fuel the desmoid tumor market further. In this context, ‘government funding’ refers to governmental financial assistance allocated for a specific purpose. It plays a significant part in propelling tumor research and treatment advancements by supporting related scientific research, medical infrastructure, and broader access to healthcare. This plays a crucial role in improving cancer prevention, diagnosis, and patient outcomes. For instance, in September 2023, the National Cancer Institute, backed by the U.S. government, was granted a budget of $7.3 billion for the fiscal year 2023 by the United States Congress for the Cancer Moonshot. This marked an increase of $408 million from the previous year. Thus, the augmenting government funding for research and development is triggering the growth of the desmoid tumor market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13228&type=smp
What is the Predicted Annual Growth Rate of theDesmoid Tumors Market Impact Industry Trends by 2034?
The market size for desmoid tumors has seen substantial growth in the past few years. The market is set to expand from $2.97 billion in 2024 to $3.18 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The historical growth can be credited to progress in medical imaging, genetic studies and comprehension, surgical advancements, heightened awareness and education, as well as patient advocacy.
The market size for desmoid tumors is anticipated to witness significant expansion in the following years, with a projected growth to $4.13 billion in 2029, marking a compound annual growth rate (CAGR) of 6.8%. The upswing in this period can be credited to factors such as targeted treatments, personalized healthcare, broader global partnerships, regulatory sanction for innovative therapies, and patient-focused strategies. The forecast period also sees trends like the development of treatment methods, precision medicine and discovering biomarkers, clinical research and trials, expansive treatment teams across disciplines, and increased focus on patient advocacy and support.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13228
Which Cutting-Edge Market Trends Are Expected to Drive theDesmoid Tumors Market’s Growth?
Leading firms active in the desmoid tumors market, are making strides in innovatively creating drugs such as nirogacestat to cater to the needs of their existing customers more efficiently. Nirogacestat is an orally taken gamma-secretase inhibitor with a small molecular structure. For example, US-based clinical-stage biopharmaceutical firm, SpringWorks Therapeutics Inc., disclosed in February 2023 that the U.S. Food and Drug Administration (FDA) had consented to and prioritized the review of their new drug application (NDA) for nirogacestat, intended for the treatment of desmoid tumors in adults. The drug is believed to operate by inhibiting the production of notch proteins, which can result in the elimination of tumor cells. Desmoid tumors are known to generate excessive amounts of notch protein, which is presumed to encourage their growth. Moreover, nirogacestat presents a novel therapeutic choice to patients that could potentially boost results.
What Are the Leading Market Players Impacting theDesmoid Tumors Market’s Growth Trend?
Major companies operating in the desmoid tumors market report are Pfizer Inc., F.Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Abbott Laboratories, Amgen Inc., Stryker Corporation, Genome And Company, Vertex Pharmaceuticals Incorporated, Eisai Limited, Beckman Coulter Inc., Incyte Corporation, Ipsen Biopharmaceuticals Inc., BeiGene Ltd., Janssen Biotech Inc., Ionis Pharmaceuticals Inc., Ayala Pharmaceuticals Inc., Blueprint Medicines Corporation, Xencor Inc., MacroGenics Inc., Debiopharm Group, Clovis Oncology Inc., Juno Therapeutics Inc., SpringWorks Therapeutics Inc., Loxo Oncology Inc., Mirati Therapeutics Inc., Iterion Therapeutics Inc., Recepta Pharmaceuticals Inc., Cellestia Biotech AG
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/desmoid-tumors-global-market-report
How Are the Key Segments of the Desmoid Tumors Market Driving Opportunities and Innovations?
The desmoid tumors market covered in this report is segmented –
1) By Treatment: Surgery, Radiation Therapy, Anti-Inflammatory Medication, Hormone Therapy, Chemotherapy, Novel Molecular-Targeted Therapy, Other Treatments
2) By Diagnosis: Biopsy, Electron Microscopic Examination, Immunohistochemical Analysis, Other Diagnosis
3) By End-User: Hospitals And Clinics, Specialty Centers, Other End-Users
Subsegments:
1) By Surgery: Wide Excision, Minimally Invasive Surgery
2) By Radiation Therapy: External Beam Radiation Therapy, Stereotactic Body Radiation Therapy
3) By Anti-Inflammatory Medication: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids
4) By Hormone Therapy: Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors
5) By Chemotherapy: Traditional Chemotherapy Agents, Combination Chemotherapy
6) By Novel Molecular-Targeted Therapy: Tyrosine Kinase Inhibitors, Other Targeted Therapies
7) By Other Treatments: Watchful Waiting, Physical Therapy, Pain Management Strategies
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13228&type=smp
What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theDesmoid Tumors Market?# Market Expansion?
North America was the largest region in the desmoid tumors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the desmoid tumors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Global Desmoid Tumors Market 2025, By The Business Research Company:
Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2024
Cancer Tumor Profiling Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report
Tumor Ablation Therapy Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
